A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

SIMPLE SUMMARY: The survival of patients with hepatocellular carcinoma (HCC) is highly variables, due to heterogeneous tumor burden and liver dysfunction. Tumor burden score (TBS) is a continuous variable to measure the extent of tumor involvement, and the albumin–bilirubin (ALBI) grade is an object...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833827/
https://www.ncbi.nlm.nih.gov/pubmed/35158917
http://dx.doi.org/10.3390/cancers14030649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833827/
https://www.ncbi.nlm.nih.gov/pubmed/35158917
http://dx.doi.org/10.3390/cancers14030649

Ejemplares similares